Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2025-12-25 @ 9:59 PM
NCT ID:
NCT05362058
Pre Assignment Details:
Participants continued their protocol-specified stable therapy with 1 to 3 non-insulin antihyperglycemic medications, including glucagon-like peptide-1 receptor agonists (GLP-1 RA), as well as non-GLP-1 receptor agonists such as dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose cotransporter 2 (SGLT2) inhibitors, biguanides (e.g., metformin), alpha-glucosidase inhibitors, sulfonylureas (SUs), or thiazolidinediones throughout the study, at the discretion of the investigator.
Study:
NCT05362058
Study Brief:
Results Section:
NCT05362058